Home › Health › Women with PMOS should get subsidised weight loss drugs,...
Health

Women with PMOS should get subsidised weight loss drugs, advocates say

Key Points

With GLP-1s to treat the condition not specifically approved by the TGA, patients are being prescribed them off-labelGet our breaking news email, free app or daily news podcastWomen living with a chronic hormonal condition should have access to taxpayer-funded weight loss medications, advocates say. The Polyendrocrine Metabolic Ovarian Syndrome Association of Australia (POSAA) is urging for GLP-1 drugs to be approved on the Pharmaceutical Benefits Scheme for people living with the condition.

With GLP-1s to treat the condition not specifically approved by the TGA, patients are being prescribed them off-label

Women living with a chronic hormonal condition should have access to taxpayer-funded weight loss medications, advocates say.

The Polyendrocrine Metabolic Ovarian Syndrome Association of Australia (POSAA) is urging for GLP-1 drugs to be approved on the Pharmaceutical Benefits Scheme for people living with the condition.

Continue reading...
TGA (ORG) The Polyendrocrine Metabolic Ovarian Syndrome Association of Australia (ORG) POSAA (ORG) the Pharmaceutical Benefits Scheme (ORG)
Originally published by The Guardian World Read original →